Statins 'effective regardless of cholesterol and CRP'
Friday 28th January 2011
Statins are effective against heart attack and stroke, regardless of levels of cholesterol and systematic inflation, according to a new study.
It was previously believed that patients with higher levels of inflammation-marker C-reactive protein (CRP) may not respond as well to the drug.
However, research published in the Lancet found that patients who took the statin drug Zocor had a 24 per cent reduction in cardiovascular events and that this was round about the same for any combination of low of high CRP and LDL cholesterol.
Jonathan Emberson, researcher, told WebMD: "CRP may be useful to help a physician understand a patient's absolute risk along with other characteristics like age, sex, blood pressure, and blood lipids."
Meanwhile, researchers from the Institute of Cancer Epidemiology, Danish Cancer Society, found that loud traffic noise can increase the risk of stroke in older adults.
Written by Martin Lambert
Related articles
Fake malaria drugs prevalent across the world
Fake drugs to prevent malaria are more prevalent than first thought, according to research by the Fogarty International Centre at...
Tuesday 22nd May 2012
Winter viruses can be combated by vitamin D
Vitamin D has been highlighted as the latest weapon in order to combat winter viruses, new research has found. The supplement is...
Monday 30th April 2012
Researchers warn against widespread use of anti...
They are one of the most commonly prescribed drugs but researchers believe that anti-depressants could actually cause more harm...
Tuesday 24th April 2012
Related Pharmacy Jobs
Locum Hospital PharmacistMediplacements are looking for a Band 6 or 7 Pharmacist for busy Hospital Pharmacy team based in the Yorkshire...
Full infoPharmacy Job Opportunities within Yorkshire.We are continually recruiting for locum Pharmacist considering locum work in Yorkshire...
Full infoPart time opportunity for a locum Pharmacy Technician within Medicines Management to work in Manchester. We currently require...
Full info